Genetic Metabolic Diseases AC's First Meeting Will Be Long On Temporary Voting Members

 
• By Sue Sutter and Derrick Gingery

The US FDA’s Genetic Metabolic Diseases Advisory Committee will comprise three regular voting members and 13 temporary members, including some adcomm veterans, when it reviews Zevra Denmark’s arimoclomol for Niemann-Pick disease type C.

Temporary and permanent
With only a few permanent members recruited so far, GeMDAC will have a lot of temporary members at its first meeting. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers